Correction: Ranbaxy Antiretroviral Drug Story From Sept. 22
The Kaiser Daily HIV/AIDS Report incorrectly stated the amount of President's Emergency Plan for AIDS Relief funding received by the Indian generic pharmaceutical company Ranbaxy. The company has received an estimated $8.9 million from PEPFAR (Business Standard, 9/21). A corrected version can be found here.This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.